Recent acquisitions helped to slightly lift the healthcare-products distributor’s profit and revenue, as the company faces ...

Cardinal Health Inc. ended its nine-year string of record revenue with a 2% decline in fiscal 2025. Here's why that was a ...

The acquisition reflects Cardinal’s expanded focus on urology in pursuit of higher growth margin versus drug distribution.

The healthcare conglomerate handily beat on the bottom line in its latest reported quarter, but that's not what the market ...

The company will acquire Solaris Health, a urology management services organization, for around $1.9 billion in cash.

Cardinal Health said on Tuesday it will buy healthcare management firm Solaris Health for $1.9 billion in cash, as the drug ...

Cardinal Health acquired Solaris Health as it continues to build out its multispecialty management services organization ...

The acquisition is meant to fuel Cardinal’s growth strategy by expanding the reach of its specialty management services organization.

Cardinal Health will acquire Solaris Health for $1.9 billion, lifting its specialty platform while posting mixed Q4 results ...

Cardinal Health dropped its share prices by 7.21 percent on Tuesday to finish at $146.3 apiece as investors soured on its ...

Guidance for fiscal 2026 EPS was raised to $9.30-$9.50, an increase of $0.20 from previous guidance, supported by both liability classification changes and stronger business performance. Pharma ...